Skip to main content
Premium Trial:

Request an Annual Quote

New Products: MS3 from Proteome Sciences and More

Premium

Proteome Sciences this week introduced its new MS3 mass spectrometry workflow using its TMT isobaric tagging reagents.

The workflow significantly reduces the ratio distortion interference seen when using standard tandem mass spec workflows with isobaric tagging, offering improved mass spec-based protein quantitation, the company said.


Bio-Rad this week launched its new Bio-Plex Pro cell signaling assays for detecting phosphorylated and total proteins in key intracellular signaling pathways.

The product consists of 34 magnetic bead-based immunoassays available both as singleplex and all-in-one formats and offers a broader dynamic range and higher sensitivity than competing immunoassays, the company said.


Genalyte this week launched the first assays for its Maverick Detection System – the Maverick ENA 4 and ENA 6 Assay Kits – both for screening for autoantibodies linked to autoimmune connective disorders.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.